Patient Dosed With Novel Combo Immunotherapy in Glioblastoma Trial 🔗 Access full article via CureTodayA novel combination immunotherapy was administered to a patient with the type of brain cancer known as glioblastoma as part of the phase 2b trial. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon